Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts
Amgen shares traded near $324.36 on Dec. 16, 2025, after the company raised its quarterly dividend to $2.52 for Q1 2026, payable March 6. The move puts Amgen’s annualized yield around 3.1%. The FDA recently approved UPLIZNA for generalized myasthenia gravis, adding to Amgen’s pipeline momentum.